“OvaScience was founded on the idea that there is an unmet need in fertility treatments… Women need more options.” – Michelle Dipp, Chief Executive Officer
OvaScience is a global life science company focused on the discovery, development, and commercialization of new fertility treatments. Our patented technology is based on egg precursor cells (EggPCSM), which are found in the outer layer of a woman’s own ovaries. The discovery of EggPCs countered a long-held medical belief that women are born with a set number of eggs, thereby enabling new possibilities in the treatment of female infertility.
Our EggPC technology has the potential to make significant advances in the field of fertility by improving egg and embryo quality due to age and other causes.